Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases

BACKGROUND AIMS: Cord blood (CB) transplantation slows neurodegeneration during certain inherited metabolic diseases. However, the number of donor cells in the brain of patients does not appear to be sufficient to provide benefit until several months after transplant. We developed the cell product D...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cytotherapy
Hlavní autoři: KURTZBERG, JOANNE, BUNTZ, SUSAN, GENTRY, TRACY, NOELDNER, PAMELA, OZAMIZ, APRIL, RUSCHE, BENJAMIN, STORMS, ROBERT W., WOLLISH, AMY, WENGER, DAVID A., BALBER, ANDREW E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843803/
https://ncbi.nlm.nih.gov/pubmed/25770677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.02.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky